1 Department of Neurology Kyung Hee University Hospital Seoul South Korea.
2 Department of Neurology Asan Medical Center University of Ulsan College of Medicine Seoul South Korea.
J Am Heart Assoc. 2018 Dec 18;7(24):e009480. doi: 10.1161/JAHA.118.009480.
Background Evidence suggests that patients with higher blood pressure variability ( BPV ) have a higher risk for stroke, but any link between BPV and stroke recurrence is unknown among those who had a stroke or transient ischemic attack ( TIA ). Methods and Results Data for patients with a history of stroke or TIA at enrollment were extracted from the ASCOT (Anglo Scandinavian Cardiac Outcomes Trial) and the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). BPV was defined as the within-subject standard deviation or coefficient of variation of systolic blood pressure across visits from 12 weeks poststroke or TIA onward. BPV was significantly higher in patients with a history of stroke or TIA than those without. BPV was a predictor of recurrent stroke in the pooled analysis. In the ASCOT study, 252 patients (12.3%) had a recurrent stroke among 2046 with a history of stroke. Incidence of recurrent stroke was significantly higher in the highest BPV quartile (17.8%) compared with the lowest quartile (10.5%); by treatment arm, this reached significance for the amlodipine-arm only (high- BPV : 18.7% versus low- BPV : 12.9%; P=0.029). Of the 2173 patients from the ALLHAT with a history of stroke or TIA , patients with the highest quartile of BPV had a higher incidence of recurrent stroke (9.6%) compared with the lowest quartile BPV (5.5%); by treatment arm, this reached significance for the chlorthalidone-arm only (high- BPV : 12.1% versus low- BPV : 5.4%; P=0.007). Conclusions Visit-to-visit BPV is a predictor of recurrent stroke in patients with a history of stroke or TIA on antihypertensive treatment. Considering BPV following a stroke may be important to reduce the risk for a recurrent stroke.
有证据表明,血压变异性(BPV)较高的患者发生中风的风险更高,但在中风或短暂性脑缺血发作(TIA)患者中,BPV 与中风复发之间的任何联系尚不清楚。
从 ASCOT(盎格鲁-斯堪的纳维亚心脏结局试验)和 ALLHAT(抗高血压和降脂治疗预防心脏病发作试验)中提取了入组时有中风或 TIA 病史的患者的数据。BPV 定义为中风或 TIA 后 12 周开始的随访期间,收缩压个体内标准差或变异系数。与无中风或 TIA 病史的患者相比,有中风或 TIA 病史的患者的 BPV 明显更高。在汇总分析中,BPV 是中风复发的预测因素。在 ASCOT 研究中,2046 例有中风病史的患者中有 252 例(12.3%)发生中风复发。最高 BPV 四分位组(17.8%)的中风复发发生率明显高于最低四分位组(10.5%);按治疗组划分,仅氨氯地平组达到显著差异(高 BPV:18.7%比低 BPV:12.9%;P=0.029)。在 ALLHAT 中有中风或 TIA 病史的 2173 例患者中,BPV 最高四分位组的中风复发发生率(9.6%)高于 BPV 最低四分位组(5.5%);按治疗组划分,仅氯噻酮组达到显著差异(高 BPV:12.1%比低 BPV:5.4%;P=0.007)。
在接受降压治疗的中风或 TIA 患者中,随访间 BPV 是中风复发的预测因素。考虑中风后的 BPV 可能对降低中风复发风险很重要。